New drug trial targets debilitating dizziness in Parkinson's patients
NCT ID NCT07089043
Summary
This study is testing an experimental oral medication called CST-3056 to see if it can reduce symptoms like dizziness and lightheadedness in people with neurogenic orthostatic hypotension (nOH), a condition that causes a severe drop in blood pressure upon standing. The trial will enroll about 12 adults with nOH, often linked to Parkinson's disease, to find the best dose and measure its effects on blood pressure and symptom severity over five days of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROGENIC ORTHOSTATIC HYPOTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CuraSen Investigational Site
RECRUITINGFarmington Hills, Michigan, 48334, United States
Contact
-
CuraSen Investigational Site
RECRUITINGEatontown, New Jersey, 07724, United States
Contact
-
CuraSen Investigational Site
RECRUITINGNew York, New York, 10019, United States
Contact
-
CuraSen Investigational Site
RECRUITINGNashville, Tennessee, 37240, United States
Contact
Conditions
Explore the condition pages connected to this study.